10000099

Organization name

Fidia Farmaceutici S.p.A.

SRN

IT-MF-000026988

Manufacturer status

Active

14 warnings recorded — scroll inside the panel to see all entries.

• CW999

  It is suggested not to use the product for a period longer than 30 days.
• CW999

  Consult your physician in case of infection complication.
• CW999

  Tetracycline should not be used locally with HYALO4 START.
• CW999

  Do not use the product concomitantly with soaps/ detergents, disinfectants containing quaternary ammonium salts, silver and other heavy metals, which can reduce the action of the product. Ask your physician the possible products to be used.
• CW999

  Do not use on exposed cartilage or tendons.
• CW999

  Avoid contact with eyes and mucosae.
• CW999

  In case of accidental ingestion or inhalation consult the physician immediately.
• CW999

  Avoid the direct contact of the container with the wound.
• CW999

  After each application put the cap back on the container.
• CW007

  EUDAMED did not publish a description for this code.
• CW999

  The product can be used up to 36 months after the first opening of the tube.
• CW032

  EUDAMED did not publish a description for this code.
• CW999

  After use, dispose according to applicable national regulations.
• CW999

  Keep out of sight and reach of children.

Primary placement in Türkiye; available across 1 country total.

Trade name

not provided

UDI-DI code

D-100000993E

Basic UDI-DI

B-100000993E

Reference / catalog number

10000099

Issuing entity

EUDAMED

Risk category

Class III

Applicable legislation

MDD [Directive 93/42/EEC on medical devices]

Status

On the market

Quantity

1

Additional product description

—

Additional information URL

No additional information URL provided by the manufacturer.

Clinical sizes

• Sodium hyaluronate 0.2%
• Collagenase NLT 2.0 nkat/g
• 30 MU24

European Medical Device Nomenclature — the EU product classification assigned to this device.

• M040499DRESSINGS FOR WOUNDS, SORES AND ULCERATIONS - OTHER